SCHEMBL23356474

SCHEMBL23356474

CCCCN(CC)CCCOc1c2occc2cc2ccc(=O)oc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 2/20 0.65
▸ KCNA3 P22001 3/20 0.60
▸ KCNA5 P22460 2/20 0.60
▸ CYP3A4 P08684 4/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP2D6 P10635 1/20 0.55
▸ CYP2A6 P11509 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ ACHE P22303 1/20 0.55
▸ PDE4A P27815 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ SLC6A3 Q01959 1/20 0.55
▸ CYP2A13 Q16696 1/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ BACE1 P56817 2/20 0.55
▸ GAA P10253 2/20 0.55
▸ ABCB1 P08183 1/20 0.55
▸ CYP1B1 Q16678 1/20 0.55
▸ RECQL P46063 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18788617 0.88 MAOA (0.78) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL18788613 0.86 MAOA (0.74) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL18788619 0.86 MAOA (0.74) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL9184365 0.84 MAOA (0.76) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL7520905 0.84 MAOA (0.68) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL7518456 0.84 MAOA (0.68) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL3446041 0.81 MAOA (0.78) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL7528121 0.80 MAOA (0.65) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL17373028 0.80 MAOA (1.00) MAOAKCNA3KCNA5CYP3A4CYP1A2
SCHEMBL8806449 0.79 CYP3A4 (0.71) MAOAKCNA3KCNA5CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3157519-B1 METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS WITH PSORALEN DERIVATIVES IMMUNOLIGHT LLC (US) 2021-05-12 — — EP disclosed
Send feedback